Providing enabling technologies to support you from Discovery to Delivery.
› News › Application and Technology News
In sterile pharmacy compounding, the goal of the pharmacist or pharmacy technician is to protect the compounded sterile preparation from cross-contamination.
Esco Pharma is pleased to launch our latest range of isolators specifically engineered to meet the growing demands of pharmacy compounding (503A and 503B) industry in the United States.
Pharmacy compounding has been present since the beginning of time. It is essential in cases such as limited dosage strengths and dosage forms, drug allergies to certain ingredients, paediatrics, chemotherapy and veterinary medicine.
The platform design with pre-proven engineering provides a perfect solution to meet a potent product formulation application with the shortest engineering and fastest delivery time.
Esco Pharma, building on the success of our suite of Aseptic/Containment Isolators, is proud to launch our Containment Barrier Isolator (CBI) range of aseptic/containment isolators. The Esco CBI retains the same functionality and platform engineering that Esco Pharma pioneered whilst adding more innovative features.
